Reproductive Tract Infections (RTIs) in women present challenges in diagnosis, management, and prevention. RTIs and women’s health are intricately intertwined, and it is important to have a comprehensive approach to testing and diagnosis. That’s why AIM Labs has developed a complete Women’s Reproductive Health panel that includes the most common sexually transmitted diseases (STDs) such as chlamydia, gonorrhea, chancroid, and human immunodeficiency virus (HIV), and endogenous infections, which are caused by overgrowth of organisms normally present in the genital tract of healthy women, such as bacterial vaginosis or vulvovaginal candidiasis.

​

RTIs are often neglected in women because they are often asymptomatic, or the symptoms are not easily recognizable. Left untreated, RTIs can result in chronic morbidity, infertility, and even neoplasia.